Alan Bash
CIK: 0001908421
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEGN
Legend Biotech Corp
Officer
Discretionary Trading P&L
Holdings
About BASH ALAN
BASH ALAN (SEC CIK 0001908421) files insider reports with the SEC as Interim CEO of Legend Biotech Corp (LEGN).
Signal8 holds 2 ownership filings by BASH ALAN (1 Form 3, 1 Form 4), filed between Aug 3, 2026 and Aug 18, 2026. Those filings report 1 transaction, the latest on Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BASH ALAN's filings is in BRIDGEWATER, NJ.
Recent filings by BASH ALAN
- Aug 14, 2026: Grant or award of LEGN shares (Form 4, code A).
Other insiders filing for Legend Biotech Corp (LEGN)
- Sanders Corazon (Corsee) D., Director
- Salovey Peter, Director
- Heyman Tomas J., Director
- Mao Li, Director
- Casey Patrick John, Director
- Ji Darren Xiaohui, Director